Replies to post #10662 on Pluristem Therapeutics Inc (PSTI)

[n3m3sis]

Quite so....

now invests a bunch of cash in a competitor, that not only has commercial products, but was spun off from a company with deep pockets and industry credibility.

For those that say that PSTI is miles ahead, perhaps so however.....

How much did it cost to get where they are now? I'm betting that it would not even make a dent in Celgene's cash supply.

Development can be accelerated a great deal if you have the funds to do it (or a Big P sugar daddy!)and do not have to wait to fund the the next step. Also, look at the others that are throwing money at this upstart startup. Thanks to EK for pointing out that they already have a source of revenue that is not grant based.

It is time Pluristem upped their game for real. They may be ahead but it wont be for long if they do not complete at least one clinical trial, get approved and start getting some sales in.

I still cannot help thinking that Celgene took this route because they couldnt hook up with Pluristem in some way. So now they have gone for a prettier, younger girlfriend.